Report Scope:
This report aims to comprehensively study the market size of AML and treatments for a global market. Current and historical market revenues can be estimated based on treatment type, route of administration, end use, distribution channel and region.

Report Includes:

  • 42 data tables and 57 additional tables
  • An overview of the global market for acute myeloid leukemia (AML) treatment
  • Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region
  • Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system
  • Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation
  • Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
  • Detailed company profiles of major players in the market of the industry, including AbbVie, Daiichi Sankyo, GlaxoSmithKline PLC, Pfizer Inc. and Servier